Course Tutors
LEARNING OUTCOMES
Upon successful completion of the course the students will be able to:
Perform specialized hematological laboratory tests.
Have an understanding of general blood testing for blood malignancies and haemostasis disorders.
Have knowledge of all blood malignancies.
Distinguish disorders of hemostasis, coagulation and fibrinolysis.
Collaborate with patients for specialized blood tests.
Use the hematology analyzers of the laboratory as well as the flow cytometry for the specialized laboratory control of the Hematological diseases.
Collaborate with his classmatesto create and present a complex hematological passage.
The aim of the course is to enable students to distinguish and process the various elements of the blood in malignant diseases of the hematopoietic tissue, such as leukemias, lymphomas, etc. both in the peripheral bloodand in the bone marrow. Also to inform students about the hemorrhagic diseases as well as the mechanism of hemostasis and thrombophilia.
Students who successfully complete the course are able to know the classification of leukemias according to theWorld Health Organization and according to FAB (French, American, British) and the clinical picture and the laboratory approach. They also will be able to know the mechanism of coagulation, hemorrhagic diseases (acquired and inherited) and the laboratory approach of coagulation disorders.
SYLLABUS
1. Differential diagnosis of white blood cells.
2. Myeloproliferative diseases (A).
3. Myeloproliferative diseases (B).
4. Myelodysplastic syndrome.
5. Acute myelogenous leukemias.
6. Acute lymphoblastic leukemia.
7. Chronic lymphogenic leukemia
8. Hodgkin’slymphoma.
9. Non-Hodgkin lymphomas (general part).
10.Differential diagnosis of coagulation disorders and hemostasis.
11.Vascular wall disorders – Vascular purpura and hereditary platelet dysfunction (thrombosis)
12.Acquired functional platelet disorders. Thrombocytopenia – general introduction and
diagnosticapproach. Hereditary thrombocytopenia. Acquired thrombocytopenia.
13.Diffuse intravascular coagulation.